USD 2.5 billion
Report ID: SQSG35I2019 | Region: Global | Published Date: November, 2022 | Pages: 165
Global allergy immunotherapy market was valued to be USD 2.5 billion in 2021, and it is anticipated to reach USD 6.2 billion by 2028 at a CAGR of 9.2% over the forecast period (2022-2028).
According to the World Allergy Organization, approximately 10-30% of the global population is currently suffering from different kinds of allergies. Allergy is the body's immune system being overly sensitive to certain substances, such as a particular meal, pollen, fur, or dust. Allergies come in many forms, including those to food, dust, pollen, latex, medications, and others. In order to build antibodies against the allergens, the body is exposed to small amounts of allergies during allergy immunotherapy. Immunotherapy uses regular, low-dose exposure to particular allergens to help the body adjust to their presence, resulting in effective and prompt allergy treatment.
The primary factors propelling the global market for allergy immunotherapy are the expansion of industrialization and population, improvements in healthcare and medicine, and the launch of new immunotherapeutic medications. To increase the market share of the global allergy immunotherapy market, recent regulatory approvals, such as those for oral dissolvable tablets, are further enhanced.
Global Market Size
USD 2.5 billion
Sublingual Immunotherapy (SLIT)
Sublingual Immunotherapy (SLIT)
To get more reports on the above market click here to Buy The Report
The Global Allergy Immunotherapy Market is segmented based on treatment type, allergy type, distribution channel and region. Based on the Treatment Type, it is categorized into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Oral Allergy Immunotherapy. Based on Allergy Type, it is categorized into Allergic Rhinitis, Asthma, Food Allergy, and Drug Allergy. Based on the Distribution Channel, it is categorized into Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies. Based on region, it is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.
Analysis by Treatment Type
On the basis of treatment type, the Sublingual Immunotherapy (SLIT) segment is projected to dominate the global allergy immunotherapy market over the forecast period. This is because it is the most efficient and popular type of allergen immunotherapy. Asthma, stinging insect hypersensitivity, and allergic rhinitis can all be effectively treated with this therapy. Additionally, SCIT has shown success in managing a variety of allergens. As a result, SCIT is more widely adopted than SLIT.
The segment for sublingual immunotherapy (SLIT) is anticipated to have the quickest CAGR throughout the projection period. For individuals who cannot receive allergy injections, SLIT is anticipated to become an essential option. SLIT pills that have received FDA approval and are currently available in the United States include Odactra, Grazax, Oralair, and Ragwitek. In the future, it is anticipated that liquid formulation will also be authorized for therapeutic use in the United States. This would accelerate the development of the SLIT market in the nation.
Analysis by Distribution Channel
On the basis of distribution channel, the hospital pharmacy segment is expected to dominate the global allergy immunotherapy market over the forecast period. This is due to an increase in the number of patients seeking treatment for allergic disorders. In order to monitor and treat any negative responses, allergy injections are typically administered in medical facilities or doctor's offices. This accelerates the segment's growth even more. In order to increase the use of the therapy, medical facilities in Belgium have suggested setting up a national registry for allergen immunotherapy in hospitals and clinics. Additionally, after a few months of therapy, SLIT can be taken at home and the medications can be ordered online.
To get detailed analysis on other segments, Request For Sample Report
Based on the region, the European region currently dominates the global allergy immunotherapy market with respect to market share, and it is projected that it will continue to hold a sizable share of the market throughout the forecast period. Due to high awareness, increased financing for research and grants, medical reimbursement rules, the rise in the population with allergies, and other factors, Europe was reported to hold the largest share of the worldwide allergy immunotherapy market. According to the European Academy of Allergy and Clinical Immunology (EAACI), 20 percent of the population in the area currently experiences chronic food allergies, which affect over 150 million people.
Asthma and allergic rhinitis are the most prevalent allergens, affecting 100 million and 70 million individuals, respectively. Furthermore, according to the organization, by 2025, 50 percent of the people in Europe would suffer from allergies, opening up a huge market for allergy immunotherapy.
The prevalence of allergies in Europe is also becoming a significant economic burden as a result of the ensuing productivity losses in European countries. In response to these issues, European governments and organizations, such as EAACI, are trying to increase public awareness and urge for better medical education and treatments, which will help the market in the area flourish.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Key players in the market are focusing on creating therapies for food allergies in particular by taking advantage of the rising prevalence of allergies. They are funding R&D initiatives in an effort to accomplish the same. To keep ahead of the curve, a number of firms are concentrating on creating new goods, including tablets and injections.
Top Players Company Profiles
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to the analysis, the global allergy immunotherapy market is currently led by countries in the European region, due to high awareness, and increased financing for research and grants in the region. Along with this, the sublingual immunotherapy (SLIT) segment is projected to dominate the global allergy immunotherapy market, due its high efficiency and popularity in the allergen immunotherapy market.
|Market size value in 2021||USD 2.5 billion|
|Market size value in 2028||USD 6.2 billion|
|Forecast Unit (Value)||USD Billion|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Allergy Immunotherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Allergy Immunotherapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Allergy Immunotherapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Allergy Immunotherapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.